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ORIGINAL ARTICLE
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STUDY QUESTION: What are the benefits and harms of receiving a polycystic ovary syndrome (PCOS) diagnosis in a community sample
of women, including impact on psychosocial wellbeing, lifestyle choices and behaviour?
SUMMARY ANSWER: Although some women benefit considerably from the diagnosis, such as through increased awareness and
reassurance, women with minimal symptoms may experience more harm than benefit, including long-lasting anxiety and altered life plans.
WHAT IS KNOWNALREADY:Disease labels can validate symptoms and play a vital role in understanding and coping with illness; however,
they can also cause harm by evoking illness schemas about severity and permanence. Regarding PCOS, the diagnostic criteria have expanded
over time to include women with milder phenotypes (such as those without signs of androgen excess). This has occurred despite limited
investigation of the benefits and harms of the diagnosis and has increased the number of women diagnosed.
STUDY DESIGN, SIZE, DURATION: Semi-structured interviews were conducted face-to-face or by telephone with 26 participants from
April–July 2018 to explore women’s experiences with the diagnosis, including the benefits and harms of receiving the diagnosis and the impact
on their life.
PARTICIPANTS/MATERIALS, SETTING, METHODS: In total, 26 women in the community self-reporting a diagnosis of PCOS
(reporting mild to severe symptoms) made by a medical doctor, aged 18–45 years and living in Australia were recruited through social media.
Data were analysed thematically using Framework analysis.
MAIN RESULTS AND THE ROLE OF CHANCE: The study identified a range of both positive and negative effects of a PCOS diagnosis
in the immediate, short and long-term, which were influenced by symptom severity, expectations and experience. For women with previously
unexplained and bothersome symptoms, it was a relief to receive a diagnosis, and this resulted in an increased understanding about the
importance of a healthy lifestyle. By contrast, women with milder symptoms often reported feeling shocked and overwhelmed by the diagnosis,
consequently experiencing anxiety about the associated long-term risks. The majority of women, regardless of symptom severity, experienced
prolonged worry and anxiety about infertility, resulting for some in risk taking with contraception, unintended pregnancies, pressure to conceive
early or altered life plans. With time, many women developed positive coping strategies and perceived the diagnosis to be valuable, including
those who felt they had experienced minimal benefit or even harm.
LIMITATIONS, REASONS FOR CAUTION: PCOS diagnosis was self-reported and the sample was highly educated.
WIDER IMPLICATIONS OF THE FINDINGS: Fear of infertility was salient for many women, underscoring the need for accurate
information, counselling and reassurance of fertility potential. Given the risk of significant consequences, health professionals should use a
tailored approach to PCOS diagnosis to increase the benefits of appropriate and timely diagnosis for women affected by significant symptoms,
while reducing the harms of unnecessarily labelling healthy women for whom the benefits of a diagnosis are small.
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WHAT DOES THIS MEAN FOR PATIENTS?
Little is known about the impact of a diagnosis of PCOS on women’s psychosocial well-being, behaviour and life choices. This is an important
issue because the definition of PCOS has expanded to include women with milder forms of PCOS (such as those without signs of androgen
excess), and therefore more women are being diagnosed.
This study explored the benefits and harms of being diagnosed with PCOS for women in the community. We found that some women
benefited greatly from a diagnosis of PCOS. For example, the diagnosis gave them an explanation for bothersome symptoms and a greater
understanding of how to look after their health. However, for women with very mild PCOS symptoms, the diagnosis often brought long-lasting
fear and anxiety with few positive effects.
Most women in the study were worried about being infertile, despite research showing many women with PCOS have the same number
of children as women without PCOS. Our study shows how fear of infertility can result in stress and anxiety, pressure to change life plans,
risk-taking with contraception and, for some, unplanned pregnancy.
These findings highlight the importance of a more tailored, personalized approach to diagnosis and providing good quality information about
fertility.
Introduction
Polycystic ovary syndrome (PCOS) is the most commonly diagnosed
endocrine disorder in women of reproductive age and is associated
with infertility and adverse reproductive, metabolic and cardiovascular
outcomes, such as insulin resistance, obesity and type II diabetes
(Dumesic et al., 2015). Symptoms of PCOS include menstrual irregu-
larities (oligo- or anovulation), signs of androgen excess [e.g. hirsutism
(male-pattern hair growth), acne] and polycystic appearing ovaries
(The Rotterdam ESHRE/ASRM PCOS Workshop, 2004).
Diagnosis can be challenging as symptoms vary in severity and it can
be difficult to differentiate normal variability from the abnormality of
PCOS, especially in young women (Skiba et al., 2018). Symptoms can
also vary by weight and ethnicity and can change across the lifespan
(Dumesic et al., 2015). Given this complexity and uncertainty, it is
not surprising that many women report experiencing long delays and
seeing multiple providers before receiving a diagnosis (Gibson-Helm
et al., 2016), resulting in a negative impact on psychosocial outcomes
and quality of life (Kitzinger and Willmott, 2002; Avery and Brau-
nack-Mayer, 2007). To add to the uncertainty, diagnostic criteria for
PCOS have expanded over time (Table I) to includewomenwithmilder
phenotypes of PCOS (such as those without signs of androgen excess),
without clear evidence of benefit (Wang and Mol, 2017), increasing
the number of women diagnosed (Copp et al., 2017a; Skiba et al.,
2018). As a result, there is concern over both underdiagnosis and
overdiagnosis of PCOS (Copp et al., 2017a; Gibson-Helm et al., 2016;
Skiba et al., 2018).
Potential benefits of receiving a PCOS diagnosis include an expla-
nation and validation of symptoms (Avery and Braunack-Mayer, 2007;
Rowlands et al., 2016). It is also suggested that a timely diagnosis may
help women with family planning, improve access to treatment and
motivate them to implement healthy lifestyle changes to reduce the
metabolic and cardiovascular risks associated with PCOS (Chan et al.,
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2017; Cooney and Dokras, 2018). However, it is unclear whether
knowledge of the diagnosis reduces these risks. Additionally, the addi-
tional phenotypes introduced by the expanded Rotterdam criteria do
not have the same increased risk of long-term implications (Daan
et al., 2014; Lizneva et al., 2016b; de Wilde et al., 2017), and current
evidence is limited by referral bias as most studies recruit women
from specialist clinics, hospital settings and PCOS support groups, who
typically have more severe symptoms than women in the community
(Azziz et al., 2016; Lizneva et al., 2016a).
This uncertain benefit of a diagnosis needs to be weighed against the
potential harms of disease labelling. An increasing body of research
in various medical conditions suggests that there are psychological,
social, physiological and behavioural harms associated with labelling
people with a medical diagnosis (Ogedegbe, 2010; Nickel et al., 2017;
Hanmer et al., 2019; Turnwald, 2019). One reason for concern over
unnecessary labelling of PCOS is that women with PCOS have higher
levels of depressive symptoms, anxiety symptoms, disordered eating
behaviours and poorer self-esteem (Dokras et al., 2011; Dokras et al.,
2012; Rowlands et al., 2016; Damone et al., 2018; Lee et al., 2018).
It is unclear whether these problems are a direct consequence of the
condition itself and its symptoms or whether they may also be due
to the PCOS label and its associated long-term implications (Moran
et al., 2012; Veltman-Verhulst et al., 2012; Cooney et al., 2017; Copp
et al., 2017b; Damone et al., 2018). Several studies suggest potential
psychological harms associated with a diagnosis of PCOS. Diagnosed
women may perceive they have poorer control over their weight
(Lin et al., 2018), despite no clear evidence of such links (Kataoka
et al., 2017; Brower et al., 2018). They may also fear infertility, despite
similar live birth rates to women without PCOS (Holton et al., 2018;
Varanasi et al., 2018). Qualitative findings of small clinical samples or
women recruited from PCOS support groups suggest that, in addition
to psychological distress (Jones et al., 2011), the prospect of infertility
may also have behavioural consequences, such as unprotected sex due
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Table I Existing diagnostic criteria for PCOS.
National Institutes of Health (1990)
(Zawadzki, 1992)
Rotterdam∗ (2003) (The Rotterdam
ESHRE/ASRM PCOS Workshop, 2004)
Androgen Excess and PCOS society (2006)
(Azziz et al., 2006)
.........................................................................................................................................................................................
Need both:
- Oligo-ovulation or anovulation
- Clinical or biochemical signs of
hyperandrogenism
And exclusion of other causes
Need two of the following:
- Oligo-ovulation or anovulation
- Clinical or biochemical signs of
hyperandrogenism
- Polycystic ovaries on ultrasound
And exclusion of other causes
Need:
- Clinical or biochemical signs of
hyperandrogenism
AND one of the following:
- Oligo-ovulation or anovulation
- Polycystic ovaries on ultrasound
And exclusion of other causes
∗Endorsed in 2018 by new international guidelines on PCOS for use in adult women (Teede et al., 2018). PCOS: polycystic ovary syndrome
to perceptions of infertility (Jones et al., 2011) or feeling pressured
to have children earlier than planned (Williams et al., 2015). Whether
women in the community and those with milder symptoms have similar
experiences is unclear.
Overall, evidence of the impact of a diagnosis of PCOS is scarce,
and no studies have explicitly investigated the benefits and harms of
receiving a diagnosis from the women’s perspective. Given the risk of
both underdiagnosis and overdiagnosis, the uncertain clinical benefit of
knowing this diagnosis needs to be weighed against the potential harms
in women labelled with PCOS.We addressed these knowledge gaps by
qualitatively exploring the balance of benefits and harms of receiving
a PCOS diagnosis for women in the community who vary in type
and severity of symptoms. In particular, we explored from women’s
perspectives the impact of the diagnosis on their psychological well-
being, lifestyle and behaviour, over the short and long term.
Materials and Methods
Design
This qualitative study used semi-structured face-to-face and telephone
interviews to explore women’s experiences with the diagnosis and
management of PCOS, including the benefits and harms of receiving
the diagnosis and the impact on their life (see SupplementaryData A for
the Consolidated Criteria for Reporting Qualitative Studies checklist).
Ethics approval
Approval was obtained through the University of Sydney Human
Research Ethics Committee (number 2017/878). Each participant
provided written informed consent.
Sample
Participants were 26 women self-reporting a diagnosis of PCOS. Inclu-
sion criteria included a diagnosis of PCOS by a medical doctor, cur-
rently aged 18–45 years and living in Australia.
Recruitment
Participants were recruited through paid Facebook advertising. Social
media was utilized in order to recruit a more diverse sample than
previous studies, which tended to recruit women from outpatient
clinics or PCOS online support groups only, where women typically
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have more severe symptoms and phenotypes (Azziz et al., 2016).
The advertisement directed interested respondents to the participant
information statement and a questionnaire (Supplementary Data B)
used to collect contact details and self-reported symptoms and severity
of PCOS. This information was used to purposively identify partici-
pants with a range of different PCOS symptoms and severity levels
(maximum variation sampling; Palinkas et al., 2015).
Given that women with milder symptoms and signs of PCOS have
been under-represented in previous literature, a second advertisement
specifically targeted to women who identified with mild PCOS was
later used to ensure that such women were well represented in the
sample. A total of 71 women expressed interest in being involved in
the study and completed the questionnaire. Thirty-seven responded
to the first advertisement (of which 19 were contacted and 18 were
interviewed) and 34 responded to the second advertisement (of which
eight were contacted and were interviewed). Recruitment continued
until preliminary analysis during data collection suggested thematic
consistency regarding the benefits and harms of receiving a PCOS
diagnosis, indicating saturation of key themes.
Data collection
The semi-structured interview guide was developed by the whole
research team, based on themes identified in previous literature and
gaps in the evidence, and reviewed by the PCOS consumer panel. The
guide was first piloted with three women with PCOS. Topics included
participants’ experience with diagnosis and management, perceived
benefits and harms of receiving the diagnosis and the impact of the
diagnosis on their life (Supplementary Data C). The interviewer was
a female public health researcher with a background in psychology
and experience with conducting qualitative interviews. Interviews were
conducted between April and July 2018, lasted 25–80 min and were
audio-recorded and transcribed verbatim.
Analysis
Interview data were analysed thematically using Framework analysis
(Ritchie, 2003). To ensure rigour, a step-by-step collaborative approach
to analysis was undertaken. Throughout data collection, the inter-
viewer (T.C.) regularly met with colleagues ( J.J., J.H., K.M., J.D.) to
discuss salient impressions as they arose, forming a preliminary list
of codes. T.C. then reviewed all transcripts and developed a list of
arising salient themes. Three more researchers (K.M., D.M. and J.J.)
read a sample of the transcripts to identify additional themes and assist
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Table II Demographics and self-reported PCOS charac-
teristics in a sample of women from the community
(N =26).
Characteristic Number (%)
of women
.....................................................................................
Current age (years)
18–25 9 (35)
26–30 6 (23)
31–35 6 (23)
36–40 2 (8)
41–45 3 (12)
Age at diagnosis (years)
12–15 3 (12)
16–20 8 (31)
21–25 12 (46)
26–30 3 (12)
Years since diagnosis
< 1 year 2 (8)
1–3 years 6 (23)
4–9 years 9 (35)
10–15 years 4 (15)
16+ years 5 (19)
Education (highest qualification
completed)
School Certificate (Year 10) 1 (4)
Higher School Certificate (Year 12) 3 (12)
Diploma/Trade certificate 6 (23)
Bachelor degree or above 16 (62)
Relationship status
Single 8 (31)
In a relationship 7 (27)
Married 11 (42)
Number of children
No children 17 (65)
1 child 4 (15)
2 or more 5 (19)
Symptoms and signs reported when
diagnosed∗
Irregular menstrual cycles 24 (92)
Polycystic ovaries on ultrasound 23 (88)
Acne (pimples) 17 (65)
Hirsutism (excess hair) 15 (58)
Weight gain 12 (46)
Alopecia (male pattern hair loss) 2 (8)
Difficulty falling pregnant 5 (19)
Number of symptoms and signs reported∗
1 symptom
2 symptoms
1 (4)
5 (19)
3 symptoms 4 (15)
4 symptoms 9 (35)
5 symptoms 5 (19)
(Continued)
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Table II Continued
Characteristic Number (%)
of women
.....................................................................................
6 or more symptoms 2 (8)
Possible phenotype of PCOS∗∗
Oligo/anovulation, signs of hyperandrogenism +
polycystic ovaries
13 (52)
Oligo/anovulation + signs of hyperandrogenism 3 (12)
Signs of hyperandrogenism + polycystic ovaries 1 (4)
Oligo/anovulation + polycystic ovaries 8 (32)
Self-reported severity of PCOS∗
Unnoticeable 3 (12)
Mild 12 (46)
Moderate 8 (31)
Severe 3 (12)
Self-reported impact of PCOS on life∗
No impact at all
Minimal
1 (4)
7 (27)
Moderate 10 (38)
Significant 6 (23)
Extremely significant 2 (8)
∗Data from responses to recruitment questionnaire (see Supplementary Data B)
∗∗phenotype is based on self-reported symptoms, so should be interpreted as a rough
guide only (n = 25 as one participant reported polycystic ovaries only but recalled her
doctor specifically diagnosing PCOS)
in drafting the coding framework, which was also informed by the
interview guide. The data set was then coded by T.C. A random subset
of the data (10%) was double coded by D.M. to ensure consistency.
Similarities or differences in the coding were discussed and re-assessed.
Prominent themes were then identified and discussed in-depth with the
research team to develop the interpretation of overall study findings.
Results
Sample characteristics
The mean age of participants was 29.3 years, over half had a bachelor
degree or higher, and most were in a relationship or married (Table II).
The majority had been diagnosed between the ages of 16 and 25 years.
The symptom that most often prompted seeking medical attention was
irregular cycles. Time since diagnosis varied from 6 months to 27 years
(median 6.5 years) and time from first seeking medical attention to
receiving diagnosis ranged from 1 week to 8 years. Participants varied
widely in symptoms reported, number of symptoms at diagnosis, self-
reported severity of PCOS and impact on life.
Thematic analysis findings
Four main themes were identified relating to the impact of being diag-
nosed with PCOS: initial appraisal, psychological impact, behavioural
consequences and coming to terms with the diagnosis. Participant
quotes are used to illustrate themes. Additionally, three case studies
highlight individual stories of women who represent diverse experi-
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ences across these four themes and differ regarding their expectations,
symptoms and experience. Pseudonyms are used throughout.
Initial appraisal
Initial appraisal and personal interpretations of the PCOS label varied
widely and were influenced by a number of factors, such as symptom
severity, pathway to diagnosis, expectations and the doctor’s approach
to communication. Some women had long suspected they might have
PCOS and were relieved to finally have an explanation for previously
ongoing, bothersome symptoms.
‘In a way relieved because I finally knew that there was some-
thing, it wasn’t just my imagination. It wasn’t just me saying,
you know, there’s something not right and nothing was found.’
(Maree, 32 years, age diagnosed: 30 years).
Others expressed feeling shocked by the diagnosis, or feeling alarmed
and overwhelmed, as they had perceived their symptoms to be rela-
tively minor and had not considered them indicating a serious condi-
tion. These feelings were further exacerbated after hearing about the
associated risks of PCOS, such as infertility, endometrial cancer and
type II diabetes.
‘This is just like really out of the blue. ‘Cause I remember like
my intention coming to the GP was, oh, my period’s just a little
bit irregular, can you put me on a pill to be regular? ...And in
my head it’s like, oh, it can’t be that serious, right? I just want
my period to be regular.’ (Gloria, 25 years, age diagnosed:
19 years).
A few women had mixed emotions, where the diagnosis initially
brought relief to have an answer for bothersome symptoms, but also
uncertainty and stress regarding their future.
‘Maybe a little bit relieved to know what was wrong with me
and that it could sort of be managed. But probably more sort of
worried about how it was going to affect me in the future.’ (Ella,
27 years, age diagnosed: 16 years).
Many expressed frustration, sadness and despair regarding the lack of
long-term solutions, contributing to feelings of dissatisfaction with the
diagnostic experience.
‘But it was also a bit upsetting to know, well we really don’t know
a lot about it, we don’t know how to cure it.’ (Louise, 43 years,
age diagnosed: 15 years).
On the other hand, a couple of participants described feeling ‘indiffer-
ent’, not bothered about their diagnosis or that it ‘didn’t really matter’
(Darcy, 20 years, age diagnosed: 20 years). These participants were
often diagnosed in their late teens or early 20’s and stated that they
were not ‘ready to hear it’ (Christina, 37 years, age diagnosed: 20 years)
or willing to engage with it, as the long-term implications seemed too
far away to consider.
‘She thought I’d be really concerned about that but really kids
is the last thing on my mind. I’m just trying to finish my degree
(laughs).’ (Darcy, 20 years, age diagnosed: 20 years).
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Psychological impact of being diagnosed with
PCOS
Women described various positive and negative impacts on their
psychological well-being as a result of being diagnosed with PCOS,
which were influenced by the symptoms they experienced and their
expectations at diagnosis.
Positive impact
For some women experiencing bothersome symptoms, the diagnosis
validated their symptoms and had a positive impact on their psychologi-
cal well-being. Prior to being diagnosed, these women described feeling
abnormal and that they were ‘turning into a boy’ (Louise, 43 years, age
diagnosed: 15 years). Receiving a medical diagnosis legitimized their
experience and made them feel less abnormal.
‘It wasn’t just me, it was actually a hormonal illness.’ (Kate,
18 years, age diagnosed: 12 years).
Some felt reassured to find out (either from their doctor or via
searching online) that PCOS is common, and benefited from knowing
they were not ‘the only person that experiences this’ (Elisabeth, 31 years,
age diagnosed: 20 years).
Many participants commented that the diagnosis brought increased
understanding and clarity about how their body works (Case study
1). Two women said this resulted in them feeling empowered and in
control regarding management, and that the diagnosis opened doors
to accessing treatment.
‘I guess mentally and emotionally I feel that it was benefit to have
that diagnosis to be explained, you know, that myriad of factors
that was sort of going on with my health. Um, it also allowed
me access to, you know, medication like Metformin, which is
typically used for diabetes management.’ (Anna, 24 years, age
diagnosed: 19 years).
Case study 1. ANNA
Anna was diagnosed at 19 years old (life stage: late adolescence) and
was 24 years when interviewed. Anna reported having symptoms
since puberty, such as seemingly inexplicable weight gain, irregular
menstruation and excess hair growth (symptoms: bothersome). She
visited the doctor about her symptoms when she was 15 years old
and was prescribed the oral contraceptive pill but was not officially
diagnosed until, aged 19 years, she raised the possibility of PCOS
to her GP herself (expectations: suspects PCOS). Anna felt ‘frus-
trated’ that the GP dismissed her symptoms as ‘just a regular part
of puberty’ and attributable to her failure in maintaining a healthy
lifestyle.
Initial reaction: For Anna, receiving the diagnosis was a ‘relief ’ as it
was something that she had suspected for some time and it ‘provided
an answer’ to symptoms, such as her weight management, which she
felt she was being ‘unfairly blamed for’.
Psychological impact: The diagnosis had a positive impact on Anna’s
well-being, as prior to being diagnosed she felt that she was being
blamed for her symptoms,which had started to impact her emotionally
and psychologically. The diagnosis gave her increased understanding
and reassurance, which stopped her from feeling at fault for her
symptoms.
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Table III Fertility-related psychosocial impacts of the PCOS diagnosis.
Psychosocial impact Supporting quote
.........................................................................................................................................................................................
Emotional impact and thought processes ‘I feel really crappy just about being diagnosed and about being diagnosed while wanting to start [trying] for a
baby’ (Harriet, 29 years, age dx:29, 0 children)
Perceived loss of control ‘The implications for fertility . . . because it’s not something that anyone wants to have decided for them. That
if you’re going to have kids or not have kids, then it feels like it should be something you choose. Like to have
that, um, imposed is quite disempowering.’ (Alex, 35 years, age dx:25, 0 children)
Threatened expectations and dreams for the
future
‘It’s challenged my whole idea of what I wanted for my future. It’s like that idea has been shaken a bit . . . I
really just don’t know what’s going to happen. What will happen if I can’t have a baby at all? And the thought
just absolutely petrifies me.’ (Harriet, 29 years, age dx:29, 0 children)
Altered parenthood goals ‘I think that I have accepted that it’s likely . . . to be difficult for me to have kids. And, um, and so . . . it’s not
something that I’ve ever really pursued.’ (Alex, 35 years, age dx:25, 0 children)
Persisting fear of infertility despite previously
conceiving naturally without difficulty
‘I remember second time round, ‘cause I was a bit older, and I was planning to have a second baby and, um
. . . I remember it didn’t happen for 6 months so I got myself quite upset by that, and thought that’s it, this is
the infertility . . . I felt like I was in a rush a little bit. I panicked. Because I sort of felt I was on the back foot
with PCOS.’ (Annette, 43 years, age dx:22, 2 children)
Fear of infertility: Learning of the risk of infertility had a negative
impact, however, as she had always ‘counted on being able to have
children’. Anna described how the diagnosis gave her ‘some concerns and
worries’ about her fertility, which were difficult to process at her age.
Behavioural consequences: Anna described how her perceptions of
her reduced fertility resulted in her taking risks with contraception as
she ‘became convinced’ that children would not be an option and ended
up falling pregnant aged 19 years. Deciding whether to continue with
the unintended pregnancy was an extremely emotional process. Anna
was concerned that she might never get pregnant again and did not feel
she would be able to live with herself if she ‘terminated a pregnancy
and then struggled in 10 years’ when she felt ready to have a child. She
described feeling ‘very angry’ that no one had told her that the effect
of PCOS on her fertility was not as severe as it was made out to be.
Anna’s understanding of her fertility from that diagnosis resulted in her
decision to continue with her pregnancy, ‘which was unexpected, and
become a single parent at aged 20.’
Coming to terms with the diagnosis: Anna described how PCOS is
now just something that she lives with and that she does not think about
it often, aside from when she would consider having more children.
Overall, Anna feels that being diagnosed with PCOS was ‘a very positive
experience’ as having the diagnosis and explanation ‘resolved a lot of
questions’ about her health. (∗Italicized text indicates verbatim quotes).
Negative impact
Some women reported feeling embarrassed by having PCOS, as for
them the diagnosis ‘sort of makes you feel like there’s something . . .
something bad wrong with you, that you have too much testosterone.’
(Ella, 27 years, age diagnosed: 16 years). Two women described how
the diagnosis threatened their self-image, as it did not fit with their
perception of being healthy.
‘I always consider myself very healthy and then I’m like, oh no,
I do have that thing (laughs).’ ( Julia, 28 years, age diagnosed:
19 years).
There were also consistent reports of diagnosis-related fear and worry
about the future. Upon receiving the diagnosis, many women expe-
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rienced persistent fears of becoming overweight or developing type
II diabetes. This included women for whom PCOS was the only
risk factor for diabetes and who were likely to be at lower risk of
metabolic consequences (such as those of normal weight without
insulin resistance).
‘I’m a little bit nervous in terms of, um, well mostly concerned
because it increases the risks of a lot of chronic diseases.’ ( Julia,
28 years, age diagnosed: 19 years).
Fear of infertility
For most women, there was a strong focus on fertility and the inherent
uncertainty the diagnosis brings. Women reported feeling ‘super sad’
(Harriet, 29 years, age diagnosed: 29 years) when contemplating their
ability to conceive and described fear of infertility being ‘always in the
background’ (Ella, 27 years, age diagnosed: 16 years). This was the
case even if they had previously conceived without difficulty. Some
participants discussed how the diagnosis and their pervasive worry
about future infertility influenced when they would start trying for a
baby. Ella, for example, described PCOS as ‘dictating’ her decision
to begin trying to conceive ‘earlier rather than later’. Some described
how their potentially reduced ability to conceive threatened their
expectations and dreams for the future, causing stress and anxiety.
Others reported beginning to question what they wanted for the
future, considering their life without children or changing their plans
to have children. Table III provides examples of these fertility-related
impacts of the PCOS diagnosis.
Behavioural consequences
Women’s reports highlighted several motivational, social and behavioural
consequences stemming from the PCOS diagnosis, with the majority
related to the associated risk of infertility.
Risk taking with contraception
Many discussed how the diagnosis and their perceptions of reduced
fertility resulted in taking risks with contraception. Three women also
reported unintended pregnancies due to the belief that they would
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need medical assistance to conceive and that contraception was likely
not necessary.
‘I basically thought that I would never get pregnant, so the
unplanned pregnancy happened . . . you really do get that argu-
ment in your head that, look it’s not easy for me, I may never get
pregnant, so you know, you’re not always that careful.’ (Louise,
43 years, age diagnosed: 15 years).
Family planning
Some women discussed feeling pressured to have children earlier than
they would have liked because they were concerned that if they left it
later they would be unable to conceive. A fewwomen did have children
earlier than preferred, which was seen to impact on their careers.
‘Yes, that did put the career on hold. I focused on having the
children early... I felt with the diagnosis, yeah, you’re always
thinking about, you know, that fertility side of it. So, yeah, it
does affect your decisions.’ (Louise, 43 years, age diagnosed:
15 years).
Some women also discussed how they would not terminate an unin-
tended pregnancy if it was to occur due to worry that it might be their
only chance to conceive (Case study 2).
‘Even if we aren’t ready we don’t really want an abortion because
it could be our only chance to create a life between us.’ (Gloria,
25 years, age diagnosed: 18 years).
Conversely, a few women were diagnosed with PCOS after experienc-
ing infertility and felt frustration and anger that the condition had not
been picked up sooner. These women often wished they had known
about the risk of infertility so they could have started trying to conceive
earlier.
‘My biggest gripe was the fact that I have had irregular periods my
whole life . . . it was only really when I was trying to get pregnant
that it was picked up . . . my husband and I probably would have
started trying to conceive much earlier.’ (Madeline, 37 years,
age diagnosed: 29 years).
There were, however, a minority of participants who reported that the
diagnosis had no impact on family planning.
‘We are trying for a second at the moment. But that’s more
looking at my age more so than anything specific with the PCOS.’
(Alison, 34 years, age diagnosed: 22 years).
Case study 2.GLORIA
Gloria was diagnosed at 18 years old (life stage: late adolescence) and
was 25 years when interviewed. Gloria was diagnosed after having
irregular periods since puberty. She was referred to a gynaecologist,
and test results showed polycystic ovaries and abnormally high andro-
gens. Gloria described having acne, but as she has had no trouble with
excess hair or weight, considers her PCOS as mild (symptoms: mild).
The gynaecologist explained to Gloria that PCOS will decrease her
fertility rate and increase her risk of diabetes.
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Initial reaction: Gloria described feeling ‘a bit scared’ when diagnosed
and described how it was a ‘serious medical condition’ and it felt ‘really out
of the blue’ (expectations: PCOS unexpected). The diagnosis for Gloria
was ‘quite confronting’, as it is something that ‘can affect your lifestyle
and quality of life’. However, Gloria reflects that ‘it could have been
a lot worse. It could have been cancer or anything. But really it’s just an
irregularity of your hormones, unfortunately.’
Psychological impact: Although being diagnosed has not changed her
way of life, Gloria reports that having the diagnosis has ‘cleared up a lot
of cloud’ in her mind and increased her understanding.
Fear of infertility: The information about her reduced fertility was
‘pretty confronting’ for Gloria as she did not think it would have any
effect on her fertility, and it has made her ‘very apprehensive’, causing
her to question whether she wants children, when to start trying for
children, and whether she should even try if her chances are already
decreased.
Behavioural consequences: Gloria discussed how she has had con-
versations with her partner about how PCOS can affect fertility and
how if they fell pregnant unintentionally they would continue with the
pregnancy even if they were not ready for a baby, due to risk of future
infertility.
Coming to terms with the diagnosis: Gloria reports that her only
worry is the uncertainty surrounding her fertility. However, she further
goes on to explain that she tries to ‘see it as a positive’ as now she has
the diagnosis she knows what to do. Overall, Gloria finds her PCOS
‘manageable’ and often forgets she has PCOS as ‘it’s really nothing’ and
it ‘doesn’t play a huge part’ in her life at the moment.
Interactions with partners
Participants reported both positive and negative impacts of the diagno-
sis on their relationships with their partners. A few women discussed
how the diagnosis placed pressure on the couple to start a family earlier
than they would have liked, and some reported feeling obligated to
discuss their diagnosis early in the relationship to make the partner
aware of their potentially reduced fertility.
‘Obviously I had to tell him about the fact that I knew I could
not conceive naturally. So that was very difficult for me. I was
very nervous ‘cause it’s a very hard thing to, to say to someone
when you’re in a new relationship and you don’t want to freak
anyone out either when it’s new, but I just felt that when you’re
with someone that they deserve to know if you feel that it’s going
to be serious.’ (Ciara, 26 years, age diagnosed: 21 years).
Others reported the diagnosis strengthened their relationship through
newfound support from their partner or gaining greater clarity as to
why they were struggling to conceive.
‘He now understands a bit better what I’m going through . . . now
that he knows it’s actually real, it’s actually a condition he’s a bit
more supportive . . . it’s actually been quite positive.’ (Maree,
32 years, age diagnosed: 30 years).
Diet and exercise changes—the good and the bad
Regarding lifestyle recommendations, some women reported the diag-
nosis was ‘a wake-up call’ (Annette, 43 years, age diagnosed: 22 years)
through increased awareness about the higher risk of developing
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type II diabetes, and it motivated them to implement healthy lifestyle
changes.
‘I’m one step ahead of knowing I might be susceptible to getting
diabetes... I lost weight, which was probably a healthy thing to
do.’ (Annette, 43 years, age diagnosed: 22 years).
However, many participants at the same time spoke of their struggle
to maintain their motivation and weight over time, illustrating the
challenge with maintaining lifestyle changes. Others discussed difficulty
in finding motivation or felt no need to alter their lifestyle. A few
participants also described becoming ‘obsessed about’ (Louise, 43 years,
age diagnosed: 15 years) maintaining a healthy lifestyle due to fear of
weight gain and developing associated problems like diabetes, which
affected their psychological well-being.
‘I was probably worried that I was going to become overweight
and maybe a little bit paranoid about making sure I didn’t eat
too much and making sure I exercised.’ (Ella, 27 years, age
diagnosed: 16 years).
Coming to terms with the diagnosis
Although participants varied in their experiences and consequences of
receiving a diagnosis of PCOS, the majority developed positive coping
strategies, such as thinking optimistically and coming to terms with the
diagnosis, either through resignation or acceptance. Some participants
also expressed forms of resilience and strengthened resolve around
their health and described their personal strength to carry on and put
things into perspective.
‘I guess just knowing that at the end of the day I have it. There’s
nothing I can do about being diagnosed with it. It is what it is.
It’s part of who I am now and just trying to take that in my
stride and deal with it in my everyday life, it’s up to me how
my thoughts are affected by it really.’ (Harriet, 29 years, age
diagnosed: 29 years).
Participants discussed the wide variation in PCOS symptom severity,
often comparing their symptoms to other women with PCOS (either
friends or others encountered online) and saying they felt fortunate
their PCOS was quite mild in comparison, illustrating their positive
outlook towards their own situation.
‘Compared to some women who have, you know, really unfortu-
nate symptoms, I’m pretty lucky . . . it could be much worse so I
don’t really mind it.’ (Amy, 31 years, age diagnosed: 15 years).
Weighing up the benefits and harms of a diagnosis
When asked to weigh up the benefits and harms, most participants
perceived the diagnosis to be more beneficial than harmful and were
glad to know they had PCOS, even those who had been negatively
impacted or considered the diagnosis to provide minimal benefit.
‘I don’t know. I think the immediate . . . the immediate benefit
to harm was definitely harmful. Um, more of the emotional and
psychological stuff . . . But I think in the long-term having that
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diagnosis helps in the physical regard to manage the symptoms
and . . . maybe not just even manage the symptoms but manage
the condition and just to be aware of it.’ (Alex, 35 years, age
diagnosed: 25 years).
A few women described an equal balance of benefits and harms, and
two women reported more harm than benefit (Case study 3).
‘I would say 50/50 definitely. Because I’ve been diagnosed, you
know, you’re aware, you can learn how your body is working,
you can learn what is good and bad for your body and how to
manage it . . . but again, harm I would say 50% because of the
mental health side of things. It can be really, you know, stressful
[in regards to fertility etc].’ (Nicole, 31 years, age diagnosed:
24 years).
Case study 3. JULIA
Julia was diagnosed at 19 years old (life stage: late adolescence), and
was 28 years when interviewed. She was diagnosed as a result of an
MRI for a hip injury, which incidentally detected polycystic ovaries. She
was referred to a gynaecologist who diagnosed herwith PCOS. Prior to
diagnosis, Julia acknowledged that she had always had irregular periods,
but did not seek medical advice as she thought it was ‘probably normal’
as she was ‘very active’ and had not really thought about it (symptoms:
minimal).
Initial reaction: The PCOS diagnosis was very unexpected and the
risks of infertility, cancer and diabetes listed by the gynaecologist was
‘a lot to take in’ so young and ‘not the most tactful of deliveries’. Julia
described feeling shocked and overwhelmed when diagnosed, as she
went in ‘with a hip injury and came out with a condition’ that she cannot
cure (expectations: PCOS unexpected).
Psychological impact: The diagnosis for Julia has had a long-
lasting emotional impact as worry about fertility and the ‘increased
risks of a lot of chronic diseases’ constantly plays on her mind and
makes her feel ‘nervous’. Julia often wonders whether it would have
been ‘better not to have known about it’ because she cannot do
anything about it except her general lifestyle factors that she does
anyway.
Fear of infertility: Julia describes how as she gets older she worries
more and more about whether she will struggle to conceive and
‘whether children will be in the future’. This has had a negative impact on
her psychological well-being as it has caused some negative moments
in terms of thinking about whether or not she can have children. This
has also resulted in some challenging conversations with her partner,
which Julia reports has been ‘the hardest part to cope with’.
Behavioural consequences: The diagnosis has resulted in Julia thinking
about trying to conceive ‘a lot earlier’ than she would have without the
diagnosis. Regarding her relationship with her partner, the diagnosis
has caused Julia to have conversations with her partner ‘early’ in their
relationship to make sure he knew about the risk of infertility before
they ‘go any further’. Julia tries to see this as ‘a good thing’ as when
they have difficulty conceiving in the future ‘he’ll know that already
rather than being a little bit more blindsided’. Julia reported making no
changes to her health behaviour after being diagnosed as she was
‘really active anyway’ and that it ‘didn’t motivate’ her to be any more
active.
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Figure 1 Summary of women’s responses to a diagnosis of PCOS and the factors that influence their response. PCOS: polycystic
ovary syndrome. The women in this study were from the general community.
Coming to terms with the diagnosis: Julia expressed both positive
and negative attitudes towards her PCOS. She called her PCOS ‘a
mild case’ when compared to other people, as she has never had
any problems with weight or acne, expressing that she felt lucky
she does not have many symptoms. However, Julia also described
how she finds the diagnosis ‘really annoying’ as it threatens her
perception of being healthy and she perceives no benefit from
knowing she has PCOS because it is not something she treats
‘in any particular way’ and often forgets to write on her medical
history.
Overall, Julia sees the diagnosis ‘as being more detrimental than being
beneficial’ and does not see ‘any benefit to having the diagnosis’ as
she does not have many symptoms, it resulted in no changes to
management, and it ‘plays on your mind’ due to ‘the associated risks and
concerns it brings up in terms of children, and risks of future diseases and
other chronic issues.’
Factors influencing the variation across themes
Women’s responses to a diagnosis and the variation across these
themes were influenced by a number of factors, including their symp-
tom severity, expectations prior to receiving a diagnosis and diagnostic
pathway, life stage, individual differences and the doctor’s commu-
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nication at diagnosis, including their description of associated long-
term implications such as infertility. The arrows in Figure 1 show these
relationships between the main themes..
Discussion
In a community sample of women diagnosed with PCOS, the
interpretation of the diagnosis and impact on their lives varied widely
and was influenced by factors such as symptom severity, expectations
and diagnostic experience. For women with bothersome symptoms,
receiving the diagnosis confirmed that their symptoms were genuine,
bringing clarity and certainty. The diagnosis provided these women a
label with which to explain their experience, positively impacting their
psychological well-being. For women with minimal symptoms or for
whom the diagnosis was unexpected, their psychological well-being
was negatively impacted, and the diagnosis mainly brought uncertainty
and worry about the future. A key theme across women was fear of
infertility, significantly affecting their lives and relationships. Regardless
of their diagnostic pathway or symptom severity, the majority of
women came to terms with the diagnosis and ultimately perceived it
to be more beneficial than harmful, even those who felt it had brought
minimal benefit or even substantial harm. Despite the range in time
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since diagnosis, no clear differences in women’s experiences were
observed.
This is the first study to explore the benefits and harms of receiving a
diagnosis of PCOS for women in the community across the spectrum
of symptom severity. The use of Facebook advertising allowed recruit-
ment of a community sample of women Australia-wide, contrasting
with previous studies that recruited from specialist clinics or PCOS
support groups. The interview schedule was developed by a multi-
disciplinary team, including experienced qualitative researchers, PCOS
experts and consumer representatives (women with PCOS), ensuring
suitability and relevance. In addition, rigorous qualitative methods
were used in analysis to reach final themes. Study limitations include
self-reported diagnosis of PCOS, although reported symptoms were
consistent with the Rotterdam criteria (except one participant who
despite reporting polycystic ovaries alone identified with the diagnosis
of PCOS) and that the sample was highly educated (61% holding a
university degree). Although the majority perceived the diagnosis to
be mainly beneficial overall, these women have already incorporated
PCOS into their identity. As a result, they are subject to biases such
as cognitive dissonance, where accepting the diagnosis facilitates the
maintenance of positive emotional well-being (Weiss and Bulmer,
2011; Hofmann, 2015).
Our findings bring together two bodies of literature regarding ben-
efits and harms of disease labelling. The benefits described are con-
sistent with previous research about the positive role of diagnostic
labels in validating symptoms and supporting patients in understanding,
responding to and coping with illness (Avery and Braunack-Mayer,
2007; Noble et al., 2019). At the same time, our findings also attest to
negative impacts of disease labelling in inducing unwarranted fear and
anxiety, activating schemas about severity and permanence, evoking
feelings of hopelessness and resulting in disengagement with treatment
and behaviours that are inconsistent with personal goals (Haynes,
1978; Scherer et al., 2013; Shaffer, 2018). More longitudinal research
is needed to assess the benefit of knowing this diagnosis on clinical
outcomes.
Additionally, women demonstrated several common misconcep-
tions about PCOS, including the belief that PCOS causes weight gain or
prevents weight loss (Lin et al., 2018), despite no evidence to suggest
this is the case (Kataoka et al., 2017; Brower et al., 2018), and that they
were likely infertile, despite similar live birth rates to women without
PCOS (Joham et al., 2014; Holton et al., 2018; Varanasi et al., 2018).
It was difficult, however, to disentangle whether these misconceptions
stemmedmainly from their doctor’s communication of associated risks
or more from the abundant misinformation about PCOS encountered
online (Chiu et al., 2018) or any pre-existing beliefs. These findings
emphasize the importance of better evidence-based communication
to women and the need to address pre-existing beliefs. Accurate infor-
mation about the likelihood of pregnancy may provide reassurance and
support more informed decision-making about contraception.
In conclusion, our findings highlight the importance of considering the
benefits and harms for each individual woman to ensure clear benefit
before ascribing the label. Harmful consequences of the diagnosis
were evident across the spectrum of symptom severity; however, the
perception of benefit was higher for certain groups, such as those with
bothersome, impactful symptoms or women struggling to conceive.
For these groups, the label seemed to offer notable advantages and
our findings highlight the importance of a timely, accurate diagnosis
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for these women. For other women, however, a label may not be
needed as the benefits of diagnosis were less clear and the risk of harm
was high (Moynihan et al., 2019). Instead symptoms could be managed
and a healthy lifestyle encouraged without a PCOS diagnosis (Copp
et al., 2017a). At the minimum, accurate information and personalized
counselling regarding long-term risks in womenwithmilder phenotypes
and minimal symptoms is needed to help alleviate anxiety and fear in
this expanding patient group.
Supplementary data
Supplementary data are available at Human Reproduction Open online.
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